Search for: "Ely Lilly" Results 181 - 200 of 2,173
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Sep 2020, 6:33 am
")Also from Eli Lilly: "Anti-inflammatory drug may shorten Covid-19 recovery time/Eli Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalized Covid-19 patients" (Politico). [read post]
24 Aug 2020, 12:00 am by Annsley Merelle Ward
Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
1 Aug 2020, 7:52 am by Pete Strom
 803.252.4800 The post Takeda, Eli Lilly to Pay $9 Billion for Actos Injuries appeared first on Strom Law Firm. [read post]
27 Jul 2020, 2:04 am by Deb Givens
The department said in a business review letter that it would allow Eli Lilly and Co., AbCellera Biologics, Amgen Inc., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
20 Jul 2020, 11:20 am by Miquel Montañá (Clifford Chance)
The patent owner (Eli Lilly & Company) sent a warning letter to the Defendant, and the latter undertook not to launch the product for which it had just obtained an MA without giving the patentee 30 days’ prior notice. [read post]
15 Jul 2020, 3:23 am by Sophie Corke
Haier judgment (discussed on the IPKat here) given the SEP/FRAND context.JUVE Patent reported on the German Federal Supreme Court's decision to uphold Eli Lilly's pemetrexed patent (a judgment in parallel Dutch proceedings is anticipated), as well as the Düsseldorf Regional Court's decision to uphold Hanwha Q-Cells' solar technology patent infringement complaint.Trade MarksMany different US organisations use the phrase 'Black Lives… [read post]
9 Jul 2020, 9:07 pm by Unknown
”Biopharmaceutical companies and foundations supporting the fund are:Almirall, Amgen, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Lundbeck, Menarini, Merck, MSD, Novartis, Novo Nordisk, Novo Nordisk Foundation, Pfizer, Roche, Shionogi, Takeda, Teva, and UCBFor more details on the AMR Action Fund, visit www.AMRActionFund.com. [read post]
5 Jul 2020, 5:43 am by Annsley Merelle Ward
  On a recent celebratory birthday call, members of IP Federation (which today include BT, Dyson, GSK, Pfizer, Ocado, Arm, Microsoft, IBM, Rolls-Royce, Shell, Merck Sharp & Dohme,  Ford and Eli Lilly) shared memories of their work, triumphs and tribulations. [read post]
18 Jun 2020, 2:24 pm by Angela Mauroni
” Various drug manufacturers, including Merck, Eli Lilly, and Amgen were joined by the Association of National Advertisers in challenging the rule in June 2019. [read post]
18 Jun 2020, 2:24 pm by Angela Mauroni
., Eli Lilly and Company, and Amgen Inc., were joined by the Association of National Advertisers, Inc. in challenging the rule in June 2019. [read post]
4 Jun 2020, 2:58 am by Dennis Crouch
Eli Lilly and Company, No. 19-1058; Dr. [read post]
27 May 2020, 3:03 am by Lynn Jokela
., Johnson & Johnson, Eli Lilly and Gilead Sciences), it seemed possible that the time had finally come for independent chairs in the pharmaceutical industry. [read post]
18 May 2020, 1:30 pm by Juvan Bonni
Krishna Ravi Srinivas: Intellectual Property Rights and Innovation in the Times of Corona Epidemic – Policy Brief (Source: SSRN) New Job Postings on Patently-O: Harrity & Harrity, LLP 2SPL Patent Attorneys Davidson Sheehan LLP Osha Liang LLP Dority & Manning Klemchuk LLP Eli Lilly & Company McNeill Baur PLLC Caldwell Intellectual Property Law Klarquist Sparkman, LLP [read post]
28 Apr 2020, 7:48 pm by Dennis Crouch
Klemchuk in Dallas Eli Lilly in Indianapolis McNeill Baur Remotely Caldwell in Boston Klarquist in Oregon [read post]
7 Apr 2020, 8:56 am by Erin Darreff
With PPE in high demand, Eli Lilly’s generosity is setting an example for other businesses to follow. [read post]